Baird cuts target for Henry Schein stock to USD 107.00
Published on 10/20/2026 at 20:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Baird cut its Henry Schein target from USD 109.00 to USD 107.00 on October 15, 2026.
- Second-quarter revenue reached USD 3.46 billion, up 6.70 percent year over year.
- Henry Schein stock was at EUR 75.25 at Lang & Schwarz on October 20, 2026 at 8:44 p.m. CEST.
- Third-quarter results are scheduled for November 3, 2026.
Henry Schein stock faces a lower Baird target of USD 107.00, while the company enters the final weeks before its third-quarter report. MarketScreener reported on October 15, 2026 that Baird reduced its target from USD 109.00 to USD 107.00. Henry Schein stock was at EUR 75.25 at Lang & Schwarz on October 20, 2026 at 8:44 p.m. CEST.
Target stays above the quote
The revised Baird target remains materially above the latest Nasdaq reference of USD 84.44 on October 20, 2026 at 2:50 p.m. ET. That leaves a USD 22.56 gap between the target and the primary-market quote, although the two prices belong to different currencies and are not combined into one percentage.
Second-quarter sales reached USD 3.46 billion
Henry Schein reported USD 3.46 billion in revenue for the second quarter of 2026, a 6.70 percent increase from the second quarter of 2025. Revenue exceeded analyst expectations by 2.60 percent, according to Yahoo Finance on October 19, 2026. The same report said Henry Schein produced the largest estimate beat among the four dental equipment and technology companies it reviewed.
What comes with the November report?
Henry Schein is scheduled to release third-quarter 2026 results before the Nasdaq opens on November 3, 2026. The company also scheduled its earnings call for 8:00 a.m. ET that day, as Business Wire reported on October 20, 2026. Analysts cited by MarketBeat expect USD 1.36 in earnings per share and USD 3.48 billion in revenue for the quarter.
Range leaves room for volatility
The Nasdaq quote stood at USD 84.44 on October 20, 2026, with a 52-week range of USD 62.15 to USD 92.18. The market capitalization was USD 9.4 billion, and the price-to-earnings ratio was 24.61. Those figures place the stock below its 52-week high while the upcoming report provides the next scheduled company-specific checkpoint.
Euro quote after the Hamburg close
The last Hamburg quote on October 19, 2026 was EUR 76.00, while Henry Schein stood at EUR 75.25 at Lang & Schwarz on October 20, 2026 at 8:44 p.m. CEST. The German venue showed a 52-week high of EUR 78.50 and a 52-week low of EUR 53.46 on its dated quote page. The further course of trading is shown by the continuously updated real-time quote of Henry Schein stock.
Henry Schein stock facts
- Company: Henry Schein, Inc.
- ISIN: US8064071025
- Ticker: HSIC
- Primary exchange: Nasdaq
- Price Lang & Schwarz as of October 20, 2026, 8:44 p.m. CEST: EUR 75.25
- Market capitalization: USD 9.4 billion as of October 20, 2026
- 52-week range: USD 62.15-92.18 as of October 20, 2026
- Sector / Industry: Healthcare / Medical Distribution
- Index membership: S&P 500
- Next earnings date: November 3, 2026
Market context: Market report S&P 500.
